This inventor holds 1 USPTO granted patent, plus 3 CIPO patents. Top assignee: Modernatx, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: John Joyal: Innovator in mRNA Quantification Methods
Introduction
John Joyal is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of molecular biology, particularly in the area of mRNA quantification. His innovative methods have the potential to enhance the accuracy and efficiency of RNA analysis.
Latest Patents
John Joyal holds a patent for mRNA quantification methods. This patent provides methods for determining the concentration of RNA, specifically mRNA, in a solution. The process involves digesting the target RNA polymer by adding a base to the RNA solution, which may include chemically modified nucleotides. The mixture is then incubated to break down the RNA into a plurality of nucleotides. Additionally, the absorbance of the digested RNA mixture is measured at 260 nm. This measurement, combined with the relative percent of each nucleotide and a mass-corrected coefficient, allows for the determination of RNA concentration. Furthermore, the patent includes computer-implemented techniques for measuring RNA concentration in a solution.
Career Highlights
John Joyal is currently associated with Modernatx, Inc., where he continues to work on innovative solutions in the field of biotechnology. His expertise in RNA quantification methods has positioned him as a valuable asset in his organization.
Collaborations
Throughout his career, John has collaborated with notable colleagues, including Nicholas J Amato and Penggao Duan. These collaborations have contributed to the advancement of research and development in their respective fields.
Conclusion
John Joyal's contributions to mRNA quantification methods exemplify his commitment to innovation in biotechnology. His work not only enhances the understanding of RNA but also paves the way for future advancements in molecular biology.